Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

26.27
+1.696.88%
Post-market: 26.500.2300+0.88%19:53 EDT
Volume:6.39M
Turnover:165.58M
Market Cap:7.41B
PE:70.62
High:26.60
Open:24.73
Low:24.32
Close:24.58
52wk High:42.50
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:1.40
T/O Rate:5.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:12.53
PE(LYR):-8.16

Loading ...

Press Release: TPG Announces Completion of $4.75 Billion Sale of Intersect to Google; Launches IPX Power as Independent Power Producer

Dow Jones
·
Mar 10

CAI Corp Sets March Board Meeting to Approve 2025 Annual Results

TIPRANKS
·
Mar 04

Bank of America Securities Keeps Their Buy Rating on Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
Feb 27

Caris Life Sciences, Inc. (CAI) Gets a Buy from BTIG

TIPRANKS
·
Feb 27

S&P 500 Futures Decline In Premarket Trading; Avidity Biosciences, Duolingo Lag

Dow Jones
·
Feb 27

Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise

Benzinga Earnings
·
Feb 27

Stock Track | Caris Life Sciences Soars 20.43% in Pre-market on Strong Earnings Beat

Stock Track
·
Feb 27

Caris Life Sciences Is Maintained at Buy by BTIG

Dow Jones
·
Feb 27

U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler

Reuters
·
Feb 27

Caris Life Sciences reports interim Achieve 1 readout for Caris Detect MCED test launch

Reuters
·
Feb 27

Stock Track | Caris Life Sciences Soars 14.70% After-Hours on Strong Q4 Earnings Beat and Upbeat Guidance

Stock Track
·
Feb 27

Earnings Flash (CAI) Caris Life Sciences Posts Q4 EPS $0.28, vs. FactSet Est of $0.03

MT Newswires Live
·
Feb 27

Caris Life Sciences Q4 total revenue hits USD 292.9 million, up 2.3x

Reuters
·
Feb 27

Caris Life Sciences - Expects Full Year 2026 Revenue to Be in the Range of $1.0 Billion to $1.02 Billion

THOMSON REUTERS
·
Feb 27

Is Caris Life Sciences (CAI) Now Attractive After Recent Share Price Weakness

Simply Wall St.
·
Feb 26

Caris Life Sciences Inc expected to post earnings of 3 cents a share - Earnings Preview

Reuters
·
Feb 25

BRIEF-Caris Life Sciences Adds Breast Cancer Signature For Capecitabine To Ai Insights

Reuters
·
Feb 24

Caris launches AI signature predicting capecitabine response in HER2-negative breast cancer

Reuters
·
Feb 24

Caris Life Sciences Inc - Adds Breast Cancer Signature for Capecitabine to AI Insights

THOMSON REUTERS
·
Feb 24